These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 20976224)

  • 1. Risk factors and immunity in a nationally representative population following the 2009 influenza A(H1N1) pandemic.
    Bandaranayake D; Huang QS; Bissielo A; Wood T; Mackereth G; Baker MG; Beasley R; Reid S; Roberts S; Hope V;
    PLoS One; 2010 Oct; 5(10):e13211. PubMed ID: 20976224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence of 2009 pandemic influenza A H1N1 infection in England: a cross-sectional serological study.
    Miller E; Hoschler K; Hardelid P; Stanford E; Andrews N; Zambon M
    Lancet; 2010 Mar; 375(9720):1100-8. PubMed ID: 20096450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of baseline age-specific antibody prevalence and incidence of infection to novel influenza A/H1N1 2009.
    Hardelid P; Andrews NJ; Hoschler K; Stanford E; Baguelin M; Waight PA; Zambon M; Miller E
    Health Technol Assess; 2010 Dec; 14(55):115-92. PubMed ID: 21208549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The dynamics of infection and the persistence of immunity to A(H1N1)pdm09 virus in Israel.
    Weil M; Shohat T; Bromberg M; Bassal R; Dichtiar R; Mandelboim M; Sofer D; Cohen D; Mendelson E
    Influenza Other Respir Viruses; 2013 Sep; 7(5):838-46. PubMed ID: 23280061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence of pandemic (H1N1) 2009 influenza infection in children and pregnant women during the 2009 influenza season in Western Australia - a seroprevalence study.
    Dowse GK; Smith DW; Kelly H; Barr I; Laurie KL; Jones AR; Keil AD; Effler P
    Med J Aust; 2011 Jan; 194(2):68-72. PubMed ID: 21241219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Infection with influenza A(H1N1)pdm09 during the first wave of the 2009 pandemic: Evidence from a longitudinal seroepidemiologic study in Dhaka, Bangladesh.
    Nasreen S; Rahman M; Hancock K; Katz JM; Goswami D; Sturm-Ramirez K; Holiday C; Jefferson S; Branch A; Wang D; Veguilla V; Widdowson MA; Fry AM; Brooks WA
    Influenza Other Respir Viruses; 2017 Sep; 11(5):394-398. PubMed ID: 28688210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Large Proportion of the Mexican Population Remained Susceptible to A(H1N1)pdm09 Infection One Year after the Emergence of 2009 Influenza Pandemic.
    Veguilla V; López-Gatell H; López-Martínez I; Aparicio-Antonio R; Barrera-Badillo G; Rojo-Medina J; Gross FL; Jefferson SN; Katz JM; Hernández-Ávila M; Alpuche-Aranda CM
    PLoS One; 2016; 11(3):e0150428. PubMed ID: 27003409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Seroepidemiology of pandemic influenza A (H1N1) 2009 virus infections in Pune, India.
    Tandale BV; Pawar SD; Gurav YK; Chadha MS; Koratkar SS; Shelke VN; Mishra AC
    BMC Infect Dis; 2010 Aug; 10():255. PubMed ID: 20738878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Post-pandemic seroprevalence of pandemic influenza A (H1N1) 2009 infection (swine flu) among children <18 years in Germany.
    von Kries R; Weiss S; Falkenhorst G; Wirth S; Kaiser P; Huppertz HI; Tenenbaum T; Schroten H; Streng A; Liese J; Shai S; Niehues T; Girschick H; Kuscher E; Sauerbrey A; Peters J; Wirsing von König CH; Rückinger S; Hampl W; Michel D; Mertens T
    PLoS One; 2011; 6(9):e23955. PubMed ID: 21915270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The seroprevalence of pandemic influenza H1N1 (2009) virus in China.
    Xu C; Bai T; Iuliano AD; Wang M; Yang L; Wen L; Zeng Y; Li X; Chen T; Wang W; Hu Y; Yang L; Li Z; Zou S; Li D; Wang S; Feng Z; Zhang Y; Yu H; Yang W; Wang Y; Widdowson MA; Shu Y
    PLoS One; 2011 Apr; 6(4):e17919. PubMed ID: 21533034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Temporal trends of influenza A (H1N1) virus seroprevalence following 2009 pandemic wave in Guangdong, China: three cross-sectional serology surveys.
    Yang F; He J; Zhong H; Ke C; Zhang X; Hong T; Ni H; Lin J
    PLoS One; 2012; 7(6):e38768. PubMed ID: 22719938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Seroprevalence of antibody to influenza A(H1N1)pdm09 attributed to vaccination or infection, before and after the second (2010) pandemic wave in Australia.
    McVernon J; Laurie K; Faddy H; Irving D; Nolan T; Barr I; Kelso A
    Influenza Other Respir Viruses; 2014 Mar; 8(2):194-200. PubMed ID: 24382379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pandemic influenza A(H1N1)pdm09 seroprevalence in Sweden before and after the pandemic and the vaccination campaign in 2009.
    Mörner A; Bråve A; Kling AM; Kühlmann-Berenzon S; Krook K; Hedenskog M; Silhammar I; Ljungman M; Ortqvist A; Andersson S; Brytting M; Thorstensson R; Linde A
    PLoS One; 2012; 7(12):e53511. PubMed ID: 23285299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Post-pandemic seroprevalence of 2009 pandemic influenza A (H1N1) virus in Shandong Province, China.
    Liu T; Li Z; Song S; Zhang S; Wang Y; Lin Y; Wang S; Wang X; Xu A; Bi Z
    Jpn J Infect Dis; 2012; 65(5):410-4. PubMed ID: 22996214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Seroprevalence study in Vojvodina (Serbia) following 2009 pandemic influenza A(H1N1)V.
    Petrović V; Reguljev Z; Nedeljković J; Ristić M
    Srp Arh Celok Lek; 2012; 140(11-12):751-5. PubMed ID: 23350250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Observational study to investigate vertically acquired passive immunity in babies of mothers vaccinated against H1N1v during pregnancy.
    Puleston RL; Bugg G; Hoschler K; Konje J; Thornton J; Stephenson I; Myles P; Enstone J; Augustine G; Davis Y; Zambon M; Nicholson KG; Nguyen-Van-Tam JS
    Health Technol Assess; 2010 Dec; 14(55):1-82. PubMed ID: 21208547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Seroprevalence following the second wave of Pandemic 2009 H1N1 influenza in Pittsburgh, PA, USA.
    Zimmer SM; Crevar CJ; Carter DM; Stark JH; Giles BM; Zimmerman RK; Ostroff SM; Lee BY; Burke DS; Ross TM
    PLoS One; 2010 Jul; 5(7):e11601. PubMed ID: 20644650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serological study of the 2009 pandemic due to influenza A H1N1 in the metropolitan French population.
    Delangue J; Salez N; Ninove L; Kieffer A; Zandotti C; Seston M; Lina B; Nougairede A; Charrel R; Flahault A; de Lamballerie X
    Clin Microbiol Infect; 2012 Feb; 18(2):177-83. PubMed ID: 21635661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Seroprevalence following the first wave of pandemic influenza A (H1N1) in Turkey, 2009.
    Gözalan A; Altaş AB; Sevencan F; Akın L; Korukluoğlu G; Kara S; Sevindi DF; Ertek M;
    Jpn J Infect Dis; 2012; 65(1):13-8. PubMed ID: 22274152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trends in seroprevalence of antibodies to pandemic influenza H1N1 (2009) virus among patients seeking care in China.
    Xu C; Bai T; Wang M; Chen T; Wang L; Chen M; Zeng Y; Fan Ch; Yuan F; Shi J; Sun S; Li D; Wang S; Feng Z; Zhang Y; Yu H; Yang W; Wang Y; Shu Y
    Acta Virol; 2012; 56(4):329-35. PubMed ID: 23237089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.